Pharmaceutical Industry Criminal and Civil Penalties: An Update

by Sabrina I. Pacifici on September 30, 2012

Pharmaceutical Industry Criminal and Civil Penalties: An Update. September 27, 2012. Sammy Almashat, M.D., M.P.H, Sidney Wolfe, M.D. Public Citizen’s Health Research Group.

  • “A total of 74 additional settlements, totaling $10.2 billion in financial penalties, were reached between the federal and state governments and pharmaceutical manufacturers between November 2, 2010 and July 18, 2012, with the first half of 2012 alone already representing a record year for both federal ($5.0 billion) and state ($1.6 billion) financial recoveries. Since 1991, a total of 239 settlements, for $30.2 billion, have now been reached (through July 18, 2012) between federal and state governments and pharmaceutical companies…On a federal level, financial penalties still continue to pale in comparison to company profits and a parent company is only rarely excluded from participation in Medicare and Medicaid for the illegal activities, which endanger the public health and deplete already overstretched taxpayer-funded programs.”
  • Previous post:

    Next post: